约旦5至11岁儿童父母接种新冠肺炎疫苗的意愿

IF 0.5 Q4 HEALTH CARE SCIENCES & SERVICES Journal of Pharmaceutical Health Services Research Pub Date : 2023-04-15 DOI:10.1093/jphsr/rmad022
F. Mayyas
{"title":"约旦5至11岁儿童父母接种新冠肺炎疫苗的意愿","authors":"F. Mayyas","doi":"10.1093/jphsr/rmad022","DOIUrl":null,"url":null,"abstract":"\n \n \n Although an emergency approval for Coronavirus Disease 2019 (COVID-19) vaccine was given for 5- to 15-year-old children, there is a public hesitancy to give it for children. This study aimed to investigate parental willingness to COVID-19 vaccine among 5- to 11-year-old children.\n \n \n \n A cross-sectional study using a self-administered questionnaire was distributed to parents from Jordan through social media and at the paediatric clinics.\n \n \n \n Six hundred and sixty-two parents participated. The mean age was 42.3 ± 2.9 years old and 67% of them were mothers. Around 60% of parents had 5- to 11-year-old children, 56% had children under 5 years, and 49.5% had 12- to 18-year-old children. About 89% of parents and 20% of their 12–18 years children had received COVID-19 vaccine. Only 37% of parents thought that COVID-19 vaccines are safe in children. Only 36/399 parents accepted the vaccine for their 5–11 years children and 232/339 rejected it. The acceptance number increased to 171 if the vaccine was a condition for school admission. Potential long-term unknown side effect was the most reported concern. Independent factors correlated with parental willingness to 5–11 years children vaccination were having a high income, having had children vaccinated to influenza vaccine, and trusting information from the government. Whereas concern of side effects was associated with vaccine rejection.\n \n \n \n Vaccine acceptance for 5- to 11-year-old children is a major issue among parents. The current study could assist the policymakers in Jordan to undertake strategies to encourage children vaccination to confine the spread of the pandemic.\n","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2023-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Parental willingness to COVID-19 vaccination among 5- to 11-year-old children in Jordan\",\"authors\":\"F. Mayyas\",\"doi\":\"10.1093/jphsr/rmad022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n \\n Although an emergency approval for Coronavirus Disease 2019 (COVID-19) vaccine was given for 5- to 15-year-old children, there is a public hesitancy to give it for children. This study aimed to investigate parental willingness to COVID-19 vaccine among 5- to 11-year-old children.\\n \\n \\n \\n A cross-sectional study using a self-administered questionnaire was distributed to parents from Jordan through social media and at the paediatric clinics.\\n \\n \\n \\n Six hundred and sixty-two parents participated. The mean age was 42.3 ± 2.9 years old and 67% of them were mothers. Around 60% of parents had 5- to 11-year-old children, 56% had children under 5 years, and 49.5% had 12- to 18-year-old children. About 89% of parents and 20% of their 12–18 years children had received COVID-19 vaccine. Only 37% of parents thought that COVID-19 vaccines are safe in children. Only 36/399 parents accepted the vaccine for their 5–11 years children and 232/339 rejected it. The acceptance number increased to 171 if the vaccine was a condition for school admission. Potential long-term unknown side effect was the most reported concern. Independent factors correlated with parental willingness to 5–11 years children vaccination were having a high income, having had children vaccinated to influenza vaccine, and trusting information from the government. Whereas concern of side effects was associated with vaccine rejection.\\n \\n \\n \\n Vaccine acceptance for 5- to 11-year-old children is a major issue among parents. The current study could assist the policymakers in Jordan to undertake strategies to encourage children vaccination to confine the spread of the pandemic.\\n\",\"PeriodicalId\":16705,\"journal\":{\"name\":\"Journal of Pharmaceutical Health Services Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2023-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Health Services Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jphsr/rmad022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Services Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jphsr/rmad022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

尽管已紧急批准为5至15岁的儿童接种2019冠状病毒病(新冠肺炎)疫苗,但公众对为儿童接种该疫苗仍犹豫不决。本研究旨在调查5至11岁儿童父母接种新冠肺炎疫苗的意愿。通过社交媒体和儿科诊所向约旦的家长分发了一份使用自填问卷的横断面研究。六百六十二名家长参加了活动。平均年龄42.3±2.9岁,其中67%为母亲。大约60%的父母有5至11岁的孩子,56%有5岁以下的孩子,49.5%有12至18岁的孩子。约89%的父母和20%的12-18岁儿童接种了新冠肺炎疫苗。只有37%的父母认为新冠肺炎疫苗对儿童是安全的。只有36/399名家长接受了5-11岁儿童的疫苗,232/339名家长拒绝了。如果疫苗是入学条件,接受人数增加到171人。潜在的长期未知副作用是最令人担忧的问题。与父母愿意为5-11岁儿童接种疫苗相关的独立因素是收入高、儿童接种过流感疫苗以及信任政府信息。而对副作用的担忧与疫苗排斥有关。5至11岁儿童接受疫苗是家长们的一个主要问题。目前的研究可以帮助约旦的政策制定者采取战略,鼓励儿童接种疫苗,以限制疫情的传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Parental willingness to COVID-19 vaccination among 5- to 11-year-old children in Jordan
Although an emergency approval for Coronavirus Disease 2019 (COVID-19) vaccine was given for 5- to 15-year-old children, there is a public hesitancy to give it for children. This study aimed to investigate parental willingness to COVID-19 vaccine among 5- to 11-year-old children. A cross-sectional study using a self-administered questionnaire was distributed to parents from Jordan through social media and at the paediatric clinics. Six hundred and sixty-two parents participated. The mean age was 42.3 ± 2.9 years old and 67% of them were mothers. Around 60% of parents had 5- to 11-year-old children, 56% had children under 5 years, and 49.5% had 12- to 18-year-old children. About 89% of parents and 20% of their 12–18 years children had received COVID-19 vaccine. Only 37% of parents thought that COVID-19 vaccines are safe in children. Only 36/399 parents accepted the vaccine for their 5–11 years children and 232/339 rejected it. The acceptance number increased to 171 if the vaccine was a condition for school admission. Potential long-term unknown side effect was the most reported concern. Independent factors correlated with parental willingness to 5–11 years children vaccination were having a high income, having had children vaccinated to influenza vaccine, and trusting information from the government. Whereas concern of side effects was associated with vaccine rejection. Vaccine acceptance for 5- to 11-year-old children is a major issue among parents. The current study could assist the policymakers in Jordan to undertake strategies to encourage children vaccination to confine the spread of the pandemic.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmaceutical Health Services Research
Journal of Pharmaceutical Health Services Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
1.50
自引率
0.00%
发文量
45
期刊最新文献
The revised patient attitudes to deprescribing (rPATD) questionnaire: an investigation using a large anonymized database Evaluation of a structured pharmacist-led intervention on glycemic control in underprivileged diabetic patients: a randomized open-label trial Cross-sectional study of pharmacists’ knowledge and beliefs about human papillomavirus, its vaccines, and barriers related to vaccine administration Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021 Navigating digital health: perspectives of Australian community pharmacists—a short communication
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1